Blog

Clinical Trial Advertisers: Take Note of These Digital Trends

By BBK Worldwide on Tue, Jun 5, 2018

The way people consume media is changing. With a projected 237.6 million estimated smartphone users by the end of 2018 in the United States alone (an increase of 13.3 million users from last year), the way people are accessing information is increasingly going mobile. Additionally, the Pew Research Center suggests that 64 percent of Americans between the ages 50 to 64 are using social media, preferring mediums like Facebook and YouTube. While the clinical trial industry is known to be slow in adopting newer technologies, the implications of these observed trends for patient recruitment speak for themselves. To get a closer look at the impact of digital media on clinical trial advertising, we spoke with our Director of Media and Research Sarah Mandracchia for her insights on some of the tactics and strategies that are shaping direct-to-consumer outreach in 2018.

Topics: advertising, clinical research, clinical trials, Digital Platforms

GDPR: Its Intent – and Its Integrity

By Rob Laurens on Wed, May 23, 2018

There are probably a good number of us in the clinical research and development industry that are spending a lot of time dotting the i’s and crossing the t’s on their Privacy Policies and otherwise ensuring that everything is ready for the 25th of May, the day that the EU’s General Data Protection Regulation (GDPR) goes into effect. And, there are probably a good number of us who have had a rather intense schedule over the past few months. But, I bet if you conducted a poll, you’d find that despite all the time-consuming work and activity, those of us concerned with the patient experience are greatly pleased that GDPR is finally here.

Agree or Disagree: Qualified Referrals Keep Sites Engaged

By BBK Worldwide on Wed, May 2, 2018

 

While sites should be held accountable for processing the referrals that are generated from clinical trial advertising, it is very important that these referrals are qualified so that sites are not wasting their time. Therefore, generating highly qualified referrals is the number one contributing factor to site engagement.

Do you agree? Disagree? Watch the latest clip from our first episode of Pharma15 Live! and leave a comment below.

Agree or Disagree: Clinical Trial Sites Must Invest in Branding

By BBK Worldwide on Mon, Apr 30, 2018

There is a difference between “advertising” to generate referrals for clinical studies and “branding” for clinical trial sites. To remain relevant in a changing media landscape, sites must allocate part of their advertising budget to invest in branding. Do you agree? Disagree? Leave a comment below.

Agree or Disagree: Regulatory Bodies Need Social Media Training

By BBK Worldwide on Wed, Apr 25, 2018

If regulatory bodies are reviewing advertising and content for digital channels, like social media, should they receive education to understand how these channels work?

Check out the latest clip from our first Pharma15 Live! debate. Do you agree? Disagree? Leave a comment below.

Topics: Social Media, clinical research

Clinical Trial Advertising: Is It Just About Referrals?

By BBK Worldwide on Mon, Apr 23, 2018

When it comes to direct-to-consumer advertising for clinical trials, is it just about generating referrals for sites? Or is the quality of the referral more important than quantity?

Watch this clip from our first Pharma15 Live! debate between industry experts. Do you agree or disagree? Comment below!

Watch On Demand: Experts Square Off on Clinical Trial Advertising

By BBK Worldwide on Fri, Mar 30, 2018

Screen Shot 2018-03-30 at 3.45.36 PMJust last week, industry experts Matt Kibby, Shwen Gwee, and Dan Sfera squared off on a live 15-minute showdown, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

Moderated by Kaitlin Kelleher, conference producer at Cambridge Healthtech Institute, our challengers were tasked with debating many of the burning issues surrounding clinical trial advertising in today's shifting patient recruitment landscape.

We're excited to present the full debate for your viewing pleasure. And for those who were unable to catch the event live, we hope you enjoy it!

Topics: advertising, clinical trials, global patient recruitment

The Debate is Heating Up!

By Aaron Fleishman on Wed, Mar 21, 2018

When it comes to clinical trial advertising, is “the juice worth the squeeze,” so to speak? To get at the heart of this issue, BBK Worldwide is bringing together industry experts to square off on the live video stream debate “Does Clinical Trial Advertising Deliver?” 

Join us on March 28th at 1:00pm EDT for a live 15-minute showdown between experts, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

With this lineup, you will not want to miss it!

Topics: Patient Recruitment, clinical trials, global patient recruitment

BBK to Attend SCOPE 2018 in Orlando

By BBK Worldwide on Thu, Feb 8, 2018

mobile-header.jpgBBK Worldwide is very excited to be participating in the 9th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 12 – 15 in Orlando FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 18 different conferences, 3 plenary keynote sessions and interactive breakout discussions.

Topics: Conferences, clinical research, life sciences

Insights from Dr. Elliot Rosenstein: Referring Physicians in Clinical Trials

By BBK Worldwide on Wed, Jan 31, 2018

 

06028f5.jpgFor our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials

 

Subscribe To Our Blog